← Back to Patent Explorer
US4673673A Expired / Lapsed US ⏱️ 0.0 years remaining

17α-alkyl-17β-hydroxy-1α-methyl-4-androsten-3-ones, their production and use pharmaceutically

Assignee: Bayer Pharma AG
•
Filing: 1985-08-06
•
Granted: 1987-06-16
•
Expires: 2005-08-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 17α-Alkyl-17β-hydroxy-1α-methyl-4-androsten-3-ones of the formula ##STR1## wherein R is a straight-chain alkyl residue of 3-8 carbon atoms, i.e., C 3-8 -n-alkyl, are pharmacologically active compounds distinguished by antiandrogenic activity, especially upon topical application.

Inventors

  • 👤 Henry Laurent
  • 👤 Rudolf Wiechert

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 20:33
CPC Classifications
C; C07; C07J; C07J21/00; C07J21/005; C07J21/006; A; A61; A61P; A61P3/00; A61P3/06; C07J1/00; C07J1/0003; C07J1/0033; C07J1/0037

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 16 words
A 17α-alkyl-17β-hydroxy-1α-methyl-4-androsten-3-one of the formula ##STR4## wherein R is n-alkyl of 7 or 8 carbon atoms.
Claim 2
Dependent Claim 16 words
A 17α-alkyl-17β-hydroxy-1α-methyl-4-androsten-3-one of the formula ##STR4## wherein R is n-alkyl of 7 or 8 carbon atoms.
Claim 3
Dependent Claim 19 words
A pharmaceutical composition comprising an antiandrogenically effective amount of a compound of claim 1 and a pharmaceutically acceptable carrier.
Claim 4
Dependent Claim 14 words
A pharmaceutical composition of claim 2 wherein the carrier is suitable for topical administration.
Claim 5
Dependent Claim 16 words
A pharmaceutical composition of claim 3 wherein the concentration of antiandrogenic compound is 0.5-5.0 wt. %.
Claim 6
Dependent Claim 31 words
A method of achieving an antiandrogenic effect in a patient in need of such treatment comprising topically administering to the patient an antiandrogenically effective amount of a compound of claim 1.
Claim 7
Dependent Claim 16 words
A method of claim 5 where the patient is suffering from acne, seborrhea, alopecia or hirsutism.

References Cited (Backward Citations)

US3391168A Cited
US3705180A Cited
US4344941A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-06-15 1990-12-15 1991-06-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-06-15 1994-12-15 1995-06-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-06-15 1998-12-15 1999-06-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag